# Peptides Studied for Type 1 Diabetes: The Trials | PepVault

Source: https://pepvault.app/conditions/type-1-diabetes

Last updated: 2026-11-19

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [By condition](https://pepvault.app/conditions) Type 1 Diabetes

Peptides by condition · Weight, blood sugar, liver and gut

# Peptides studied for type 1 diabetes

Checked November 2026 against our study pages and the FDA labels [Published by PepVault](https://pepvault.app/guides/how-we-research)

Our library holds 5 study pages on type 1 diabetes: 5 in people (4 of them meta-analyses or randomized trials). They studied 2 compounds, with this many study pages each: Pramlintide 4 and Semaglutide 1.

## What the research on type 1 diabetes looks like

Type 1 diabetes is an autoimmune disease in which the body destroys the cells in the pancreas that make insulin, so people need insulin for life. Those same cells also make amylin, a hormone released with insulin at meals. The peptide research here centers on pramlintide, a copy of amylin, given alongside mealtime insulin, with one trial of a GLP-1 drug in adults with type 1 diabetes and excess weight.

These studies measure HbA1c, a blood test of average blood sugar over the past few months, the rise in blood sugar after a meal, and the share of the day that blood sugar stays in the target range on a glucose sensor. Weight and low blood sugar episodes are tracked too.

Low blood sugar is the main risk when anything is added to insulin, so look at how often it happened. Several of these studies were small or short, some lasting days rather than months, which differs from years of daily life with the disease.

How many of the 5 study pages on this condition reach each design, strongest at the top: meta-analyses and randomized trials in people, other studies in people, animals, cells.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## The 5 studies, by compound

Grouped by the compound each study is filed under, and within each, strongest design first. Each line gives the design, who was studied, how many and the year, before the finding.

1. ### [Pramlintide](https://pepvault.app/peptides/pramlintide)

   4 in people

   For type 1 diabetes, 4 of our study pages are filed under Pramlintide: 3 randomized trials and 1 clinical trial in people. The largest in people enrolled 80 people and was published in 2024. They were published from 2009 to 2025, in Diabetes Obes Metab, J Diabetes Sci Technol and Endocr Pract.

   FDA-approved, with a use tied to type 1 diabetes on its label: Symlin for adding to mealtime insulin in type 1 or type 2 diabetes when insulin alone has not reached the blood sugar goal.

   - Randomized trial in people · 80 people · 2024 [Pramlintide-insulin mix: 2.1 kg more weight loss than lispro](https://pepvault.app/research/pramlintide-andersen-2024)
   - Randomized trial in people · 12 people · 2025 [Pramlintide-insulin loop: time in range held without carb counting](https://pepvault.app/research/pramlintide-odabassian-2025)
   - Randomized trial in people · 2023 [Pramlintide/insulin ADO09 cut meal glucose rise 69% in high-dose group](https://pepvault.app/research/pramlintide-andersen-2023)
   - Clinical trial in people · 11 people · 2009 [Pramlintide pump infusion: HbA1c fell 0.35% in 16-week pilot](https://pepvault.app/research/pramlintide-huffman-2009)

   - [Symlin, from its FDA label](https://pepvault.app/drugs/symlin)
   - [Pramlintide: legal and regulatory status](https://pepvault.app/peptides/pramlintide/legal-status)
   - [Pramlintide in the library](https://pepvault.app/peptides/pramlintide)
   - [Pramlintide dose guide](https://pepvault.app/lab/dosage/pramlintide)
2. ### [Semaglutide](https://pepvault.app/peptides/semaglutide)

   1 in people

   For type 1 diabetes, 1 of our study pages is filed under Semaglutide: 1 randomized trial in people. It enrolled 72 people and was published in 2025, in NEJM Evid.

   FDA-approved for other uses, not for type 1 diabetes: Ozempic (injection) for blood sugar control in adults with type 2 diabetes, and lowering the risk of heart attack, stroke and kidney decline in those with heart or kidney disease; Rybelsus (tablet) for blood sugar control in adults with type 2 diabetes, and lowering the risk of heart attack and stroke in those at high risk; Wegovy (injection) for weight loss and keeping it off, lowering heart risk in adults with heart disease and excess weight, and a fatty-liver disease (MASH) with moderate to advanced scarring; Wegovy (tablet) for weight loss and keeping it off, and lowering heart risk in adults with heart disease and excess weight; Ozempic (tablet) for blood sugar control in adults with type 2 diabetes, and lowering the risk of heart attack and stroke in those at high risk (the same label as Rybelsus).

   - Randomized trial in people · 72 people · 2025 [Semaglutide: 36% vs 0% hit glucose and weight goal in type 1 diabetes](https://pepvault.app/research/semaglutide-adjust-t1d-2025)

   - [Semaglutide: legal and regulatory status](https://pepvault.app/peptides/semaglutide/legal-status)
   - [Semaglutide in the library](https://pepvault.app/peptides/semaglutide)
   - [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

## On type 1 diabetes

### Pramlintide

- [Pramlintide: the full reference](https://pepvault.app/peptides/pramlintide)
- [Pramlintide dose guide](https://pepvault.app/lab/dosage/pramlintide)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Pramlintide: HbA1c down 0.43% vs placebo at 26 weeks with insulin](https://pepvault.app/research/pramlintide-hollander-2003)
- [Pramlintide-insulin loop: time in range held without carb counting](https://pepvault.app/research/pramlintide-odabassian-2025)
- [Pramlintide-insulin mix: 2.1 kg more weight loss than lispro](https://pepvault.app/research/pramlintide-andersen-2024)
- [All 8 studies](https://pepvault.app/research#pramlintide)
- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Cagrilintide vs Pramlintide](https://pepvault.app/peptides/compare/cagrilintide-vs-pramlintide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Related conditions

- [Peptides studied for obesity](https://pepvault.app/conditions/obesity)
- [Peptides studied for type 2 diabetes](https://pepvault.app/conditions/type-2-diabetes)
- [Peptides studied for fatty liver disease (MASH)](https://pepvault.app/conditions/fatty-liver-disease)
- [Peptides studied for heart disease](https://pepvault.app/conditions/heart-disease)

### By goal

- [Peptides for weight loss](https://pepvault.app/peptides/for/weight-loss)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)

## Side by side

For the 2 compounds on this page: studies in people, studies in animals or cells, the size of the largest study in people, and the FDA status from the labels our status pages read (a dash where they hold no record).

| Compound | In people | Animals or cells | Largest in people | FDA |
| --- | --- | --- | --- | --- |
| [Pramlintide](https://pepvault.app/peptides/pramlintide) | 4 | 0 | 80 | Approved, a use tied to it |
| [Semaglutide](https://pepvault.app/peptides/semaglutide) | 1 | 0 | 72 | Approved for other uses |

## What the studies did not show

Each study page names its own limits. These are the questions still open, in the study pages’ words.

- [Pramlintide-insulin mix: 2.1 kg more weight loss than lispro](https://pepvault.app/research/pramlintide-andersen-2024) This was a short 16-week trial with 80 people. It tested pramlintide only as part of a mixed product with insulin A21G, so it does not show the effect of pramlintide on its own.
- [Pramlintide-insulin loop: time in range held without carb counting](https://pepvault.app/research/pramlintide-odabassian-2025) This was a pilot trial in only 12 adults, with each setup tested for just 14 hours, so it cannot show how the system performs over weeks or months. The authors say a longer and larger study is underway.
- [Semaglutide: 36% vs 0% hit glucose and weight goal in type 1 diabetes](https://pepvault.app/research/semaglutide-adjust-t1d-2025) This was a small, 26-week trial, so it can't show longer-term effects or rarer side effects. Everyone used an AID system, so the result may not apply to people with type 1 diabetes on other insulin setups.

This page is a reading of published studies, not medical advice. A diagnosis, and what to do about it, is a conversation with a clinician.

## Related pages

- [Peptides studied for obesity 1 study in common](https://pepvault.app/conditions/obesity)
- [Peptides studied for type 2 diabetes 2 compounds in common](https://pepvault.app/conditions/type-2-diabetes)
- [Peptides studied for fatty liver disease (MASH) 1 compound in common](https://pepvault.app/conditions/fatty-liver-disease)
- [Peptides studied for heart disease 1 compound in common](https://pepvault.app/conditions/heart-disease)

### By goal

- [Peptides for weight loss](https://pepvault.app/peptides/for/weight-loss)

### Trial terms

- [Randomized controlled trial (RCT)](https://pepvault.app/glossary/randomized-controlled-trial)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Phase 1, 2 and 3 trials](https://pepvault.app/glossary/clinical-trial-phases)
- [Meta-analysis](https://pepvault.app/glossary/meta-analysis)

## Questions

### Which peptides have been studied for type 1 diabetes?

Our 5 study pages on type 1 diabetes are filed under 2 compounds, with this many each: Pramlintide 4 and Semaglutide 1. Pramlintide has the most.

### Have any been tested in people with type 1 diabetes?

Yes: all 5 were in people, 4 of them meta-analyses or randomized trials (Pramlintide and Semaglutide). The largest enrolled 80 people: “Pramlintide-insulin mix: 2.1 kg more weight loss than lispro” (2024).

### Is any peptide FDA-approved for type 1 diabetes?

Yes, with a use tied to type 1 diabetes on their FDA labels: Pramlintide as Symlin. 1 other compound here with an FDA record has no use tied to it.

### How large were the studies in people on type 1 diabetes?

Of the 5 in people, 4 give their size on our pages: 4 had fewer than 100. The largest, a randomized trial from 2024, enrolled 80.

### What is the newest study on type 1 diabetes here?

Of our study pages on type 1 diabetes, the newest is “Semaglutide: 36% vs 0% hit glucose and weight goal in type 1 diabetes”, a randomized trial in people published in 2025.

## How this page was built

A study page is listed here only where we read its question, design and finding and the study was about this condition: its subjects had the condition, or were an animal or cell model of it, and the study gave them the compound. A study that only mentions the condition is not listed.

Studies are grouped by the compound each is filed under and ordered by design: meta-analyses and randomized trials in people first, then other studies in people, then animals, then cells, and within a group by size and then by year. The FDA status comes from the labels our legal-status and brand pages read.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## On type 1 diabetes

### Pramlintide

- [Pramlintide: the full reference](https://pepvault.app/peptides/pramlintide)
- [Pramlintide dose guide](https://pepvault.app/lab/dosage/pramlintide)

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Pramlintide: HbA1c down 0.43% vs placebo at 26 weeks with insulin](https://pepvault.app/research/pramlintide-hollander-2003)
- [Pramlintide-insulin loop: time in range held without carb counting](https://pepvault.app/research/pramlintide-odabassian-2025)
- [Pramlintide-insulin mix: 2.1 kg more weight loss than lispro](https://pepvault.app/research/pramlintide-andersen-2024)
- [All 8 studies](https://pepvault.app/research#pramlintide)
- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)

### Compared with

- [Cagrilintide vs Pramlintide](https://pepvault.app/peptides/compare/cagrilintide-vs-pramlintide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Related conditions

- [Peptides studied for obesity](https://pepvault.app/conditions/obesity)
- [Peptides studied for type 2 diabetes](https://pepvault.app/conditions/type-2-diabetes)
- [Peptides studied for fatty liver disease (MASH)](https://pepvault.app/conditions/fatty-liver-disease)
- [Peptides studied for heart disease](https://pepvault.app/conditions/heart-disease)

### By goal

- [Peptides for weight loss](https://pepvault.app/peptides/for/weight-loss)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [HbA1c (A1C)](https://pepvault.app/glossary/hba1c)

<!--promo-->

PepVault for iPhone

## Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=conditions-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## By condition

- [Every condition](https://pepvault.app/conditions)
- [Peptides studied for obesity](https://pepvault.app/conditions/obesity)
- [Peptides studied for type 2 diabetes](https://pepvault.app/conditions/type-2-diabetes)
- [Peptides studied for fatty liver disease (MASH)](https://pepvault.app/conditions/fatty-liver-disease)
- [Peptides studied for heart disease](https://pepvault.app/conditions/heart-disease)

## The research

- [Studies, in plain English](https://pepvault.app/research)
- [The peptide reference library](https://pepvault.app/peptides)
- [Peptides by goal](https://pepvault.app/peptides/for)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
